Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the joint meeting of the National
Cancer Advisory Board and NCI Board of Scientific Advisors.
The meeting will be held as a virtual meeting and is open to the
public. Individuals who plan to view the virtual meeting and need
special assistance or other reasonable accommodations to view the
meeting, should notify the Contact Person listed below in advance of
A portion of the National Cancer Advisory Board meeting will be
closed to the public in accordance with the provisions set forth in
section 552b(c)(6), Title 5 U.S.C., as amended, for the review,
discussion, and evaluation of individual intramural programs and
projects conducted by the National Cancer Institute, including
consideration of personnel qualifications and performance, and the
competence of individual investigators, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Advisory Board and NCI Board
of Scientific Advisors.
Date: April 9, 2020.
Open: 1:00 p.m. to 3:15 p.m.
Agenda: Joint meeting of the National Cancer Advisory Board and
NCI Board of Scientific Advisors, NCI Director's report and other
Closed: 3:15 p.m. to 4:00 p.m.
Agenda: Review of ongoing intramural research efforts and the
discussion of confidential personnel issues.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Rockville, MD 20850 (Virtual Meeting).
Instructions regarding access to the meeting can be found here:
Contact Person: Paulette S. Gray, Ph.D., Executive Secretary,
Division of Extramural Activities, National Cancer Institute--Shady
Grove, National Institutes of Health, 9609 Medical Center Drive, 7th
Floor, Room 7W444, Bethesda, MD 20892, 240-276-6340,